Cell Signaling Technology

Phospho-TAK1 (Thr184) Antibody

#4537 · $362

100
Citing papers
11.1k
Combined citations
Supplier page Find this product

Research areas

Immune Response and Inflammation11MicroRNA in disease regulation10RNA modifications and cancer8Wnt/β-catenin signaling in development and cancer6Kruppel-like factors research6Cancer-related molecular mechanisms research6Immune Cell Function and Interaction6Neutrophil, Myeloperoxidase and Oxidative Mechanisms5

Papers citing this product

1
FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment
Development·2007·805 cit.·DOI
2
Toll-like Receptors Induce a Phagocytic Gene Program through p38
The Journal of Experimental Medicine·2003·428 cit.·DOI
3
SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+T-cells
Retrovirology·2012·319 cit.·DOI
4
Role of Toll‐Like Receptors on Human Adipose‐Derived Stromal Cells
Stem Cells·2006·281 cit.·DOI
5
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer
Nature·2012·257 cit.·DOI
6
Inhibiting Glycosphingolipid Synthesis Improves Glycemic Control and Insulin Sensitivity in Animal Models of Type 2 Diabetes
Diabetes·2007·239 cit.·DOI
7
Multiple TLRs Are Expressed in Human Cholangiocytes and Mediate Host Epithelial Defense Responses to <i>Cryptosporidium parvum</i> via Activation of NF-κB
The Journal of Immunology·2005·238 cit.·DOI
8
TLRs Govern Neutrophil Activity in Aspergillosis
The Journal of Immunology·2004·238 cit.·DOI
9
Ligand-regulated Chimeric Receptor Approach Reveals Distinctive Subcellular Localization and Signaling Properties of the Toll-like Receptors
Journal of Biological Chemistry·2004·234 cit.·DOI
10
Landscape of pathogenic mutations in premature ovarian insufficiency
Nature Medicine·2023·211 cit.·DOI
Phospho-TAK1 (Thr184) Antibody — Evidence — PubIndex